# SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites

> **NCT06991478** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Solid Tumor, Malignant Ascites

## Interventions

- **DRUG:** SK-NK injection
- **DRUG:** SK-NK injection

## Key facts

- **NCT ID:** NCT06991478
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-30
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-07-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991478, "SK-NK Injection in Patients With Advanced Solid Tumors Accompanied by Malignant Ascites". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06991478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*